Dr. Khan on Retrospective Analysis of Demographics in CRC and Gastric Cancer
Amir Khan, MD, discusses a large retrospective database analysis on colorectal cancer and gastric cancer presented at the 2020 Gastrointestinal Cancers Symposium.
Dr. Khan on Overall Incidence of Gastric Cancer and CRC
Amir Khan, MD, discusses trends in the overall incidence of gastric cancer and colorectal cancer.
Dr. Kahn on Rising Incidence in Gastric and CRC in Young Adult Patients
Amir Khan, MD, discusses the rising incidence of gastric and colorectal cancers in young adult patients.
PD-1 Inhibitor Combinations, Alternative Therapeutic Approaches Are Moving the Needle in NSCLC
Better Understanding of Biomarkers Can Inform Immunotherapy Treatment in SCLC
Second-Line Treatment of R/R LBCL With Lisocabtagene Maraleucel (Liso-cel)
ZUMA-7: Axicabtagene Ciloleucel as a Second-Line Therapy for LBCL
2 Clarke Drive Cranbury, NJ 08512